Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience J.F. Fisher, K. Woeltje, A.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Vaccines for the elderly

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Anidulafungin for the treatment of invasive candidiasis

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Herpes zoster in non-hospitalized children

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

Isospora belli infection in a patient with non-Hodgkin's lymphoma

Structure of grepafloxacin relative to activity and safety profile

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Field evaluation of a second-generation cytometer UF-100 in diagnosis of acute urinary tract infections in adult patients F. Manoni, S. Valverde, F.

Training for the infectious diseases speciality in Norway

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health R.M. Davies Clinical Microbiology and Infection

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

Sepsis and neutropenia induced by clozapine

Uncommon opportunistic fungi: new nosocomial threats

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

Pathogenesis of catheter-related infections: lessons for new designs

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Community-acquired pneumonia: epidemiologic and clinical consideration

Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients S. Oliveri, L. Trovato, P. Betta, M.G. Romeo,

Training in infectious diseases and tropical medicine in Britain

Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women F. Auquer, F. Cordón, E. Gorina, J.C. Caballero,

Reducing antibiotic use in influenza: challenges and rewards

A.P. Underwood, J. Green Clinical Microbiology and Infection

Fibronectin concentrations in catheter sepsis

Vaccines for the elderly

Clinical infection services—the Leiden experience

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Statin use and clinical outcomes among pneumonia patients

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis Miles Denton, Kevin G Kerr, Fraser Lewis Clinical.

Clinical Microbiology and Infection

Evaluation of the performance of the Helico Blot 2

Overview of cefixime use in community-acquired infections

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† C.B. Moore,

J.L. Balcázar Clinical Microbiology and Infection

Typing of Clostridium difficile

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party Dilip Nathwani, Christopher Conlon Clinical.

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience J.F. Fisher, K. Woeltje, A. Espinel-Ingroff, J. Stanfield, J.T. DiPiro Clinical Microbiology and Infection Volume 9, Issue 10, Pages 1024-1027 (October 2003) DOI: 10.1046/j.1469-0691.2003.00711.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Graph depicting duration of urinary excretion of amphotericin B (AmB) following a single IV dose of 0.3–1.0 mg/kg in three patients (adapted from [11] with permission). Clinical Microbiology and Infection 2003 9, 1024-1027DOI: (10.1046/j.1469-0691.2003.00711.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions